72 related articles for article (PubMed ID: 2079482)
21. [Congenital dyserythropoietic type II anemia complicated by extramedullary hematopoiesis in the posterior mediastinum].
Indrák K; Herman M; Dusek J; Dusková M; Gumulec J; Slezák P; Hubácek J; Faber E; Wiedermann B
Vnitr Lek; 1995 Oct; 41(10):704-9. PubMed ID: 8578704
[TBL] [Abstract][Full Text] [Related]
22. Congenital dyserythropoietic anaemia (CDA) type I--a case report with ultrastructural study.
Ghosh K; Mohanty D; Bhagwat AG; Das KC
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):716-22. PubMed ID: 2416648
[TBL] [Abstract][Full Text] [Related]
23. Congenital dyserythropoietic anemia type I.
Holla RG; Mishra DK; Prasad AN
Indian J Pediatr; 2010 Feb; 77(2):215-6. PubMed ID: 20012793
[No Abstract] [Full Text] [Related]
24. Progress in the congenital dyserythropoietic anemias: juicy but high-hanging fruits?
Renella R
Am J Hematol; 2010 Dec; 85(12):913-4. PubMed ID: 21108324
[No Abstract] [Full Text] [Related]
25. Ultrastructural, cell culture and karyotype study of bone marrow in a patient with congenital dyserythropoietic anaemia (CDA)-type III presenting with recurrent still-births.
Ghosh K; Yavagal D; Phillips C; Jijina F; Pathare AV; Kerketta L; Iyer YS; Nair CN; Shinde S; Mohanty D
Haematologia (Budap); 1998; 29(1):41-5. PubMed ID: 9704256
[TBL] [Abstract][Full Text] [Related]
26. Benign clinical phenotype of co-inherited congenital dyserythropoietic anaemia type I and heterozygous haemoglobin Lepore.
Li EW; Walsh R; Ho PJ
Eur J Haematol; 2023 Jul; 111(1):161-164. PubMed ID: 37037770
[No Abstract] [Full Text] [Related]
27. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
Heimpel H
Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the existence of two populations of erythroid cells in a case of congenital dyserythropoietic anaemia type II.
Cazzola M; Barosi G; Lambertenghi-Deliliers G; Paolini F; Riccardi A
Haematologica; 1982 Aug; 67(4):508-16. PubMed ID: 6815010
[No Abstract] [Full Text] [Related]
29. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
30. Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia.
Oh A; Patel PR; Aardsma N; Mehendale SR; Chowdhery R; Sweiss K; Rondelli D
Bone Marrow Transplant; 2017 Jun; 52(6):905-906. PubMed ID: 28319077
[No Abstract] [Full Text] [Related]
31. Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I.
Roberts E; Madhusudhana KC; Newsom R; Cullis JO
Br J Haematol; 2006 Jun; 133(5):456. PubMed ID: 16681633
[No Abstract] [Full Text] [Related]
32. Lethal hydrops fetalis due to congenital dyserythropoietic anemia in a newborn: association of a new skeletal abnormality.
Tekinalp G; Sarici SU; Erdinç AS; Gögüş S; Balci S; Gürgey A
Pediatr Hematol Oncol; 2001 Dec; 18(8):537-42. PubMed ID: 11764104
[TBL] [Abstract][Full Text] [Related]
33. Paravertebral extramedullary haemopoiesis occurring in a case of congenital dyserythropoietic anaemia type II.
Imran A; Mawhinney R; Swirsky D; Hall C
Br J Haematol; 2008 Jan; 140(1):1. PubMed ID: 17868044
[No Abstract] [Full Text] [Related]
34. [Erythroid colonies derived from BFU-E from the bone marrow in a patient with type I congenital dyserythropoietic anemia].
Florensa L; Woessner S; Almarcha J; Pardo Peret P; Lafuente R; Vilá RM
Sangre (Barc); 1990 Jun; 35(3):219-21. PubMed ID: 2396168
[TBL] [Abstract][Full Text] [Related]
35. [Secondary iron overload].
Galacteros F
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215
[No Abstract] [Full Text] [Related]
36. Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).
Izzo P; Spagnuolo A; Manicone A; Nazzaro P; Lauta VM
Clin Hemorheol Microcirc; 1999; 21(3-4):425-30. PubMed ID: 10711781
[TBL] [Abstract][Full Text] [Related]
37. [Congenital dyserythropoietic anemia morphologically type I with a positive HEMPAS phenomenon].
Bergua Burgués JM; Navarro D; González J; Doblaré E
Sangre (Barc); 1998 Feb; 43(1):59-61. PubMed ID: 9577182
[TBL] [Abstract][Full Text] [Related]
38. Congenital dyserythropoiesis type I and alpha-interferon therapy.
Virjee S; Hatton C
Br J Haematol; 1996 Sep; 94(3):581-2. PubMed ID: 8790164
[No Abstract] [Full Text] [Related]
39. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Ramos J; Delfour C; Henry L; Guiraud I; Carillo S; Wagner A; Bureau JP; Blanc P
Eur J Haematol; 2004 Nov; 73(5):380-3. PubMed ID: 15458519
[TBL] [Abstract][Full Text] [Related]
40. Variants of congenital dyserythropoietic anaemia: an update.
Boogaerts MA; Verwilghen RL
Haematologia (Budap); 1982; 15(2):211-9. PubMed ID: 6761240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
